Table 2.
Association of study site, age, and sex with retention of immune responses between February 2003 and November 2004
| Antibody response |
ELISPOT |
|||||
|---|---|---|---|---|---|---|
| 3D7 |
FVO |
3D7 |
||||
| OR | 95% CI | OR | 95% CI | OR | 95%CI | |
| Residence in Kisumu | 3.34 | 0.85–15.80 | 2.21 | 0.58–8.30 | 2.49 | 0.67–10.22 |
| Age (per year) | 1.01 | 0.86–1.20 | 1.04 | 0.90–1.11 | 1.04 | 0.89–1.23 |
| Female sex | 0.74 | 0.18–2.82 | 0.97 | 0.53–1.80 | 0.31 | 0.07–1.21 |
CI = confidence interval; ELISPOT = enzyme-linked immunosorbent spot assays; OR = odds ratio. ORs were not calculated for ELISPOT for FVO because no child with a positive interferon-gamma ELISPOT for FVO in 2003 retained it.